A phase ll study of trastuzumab in combination with triweekly S-1 plus CDDP in HER2-positive advanced gastric cancer ; OGSG1101, HGCSG1102, T-CORE1101 Intergroup study (HERBIS-1 trial)
国際学会発表
A phase ll study of new combination regimen with trastuzumab, S-1 and CDDP in HER2- positive advanced gastric cancer; OGSG1101, HGCSG1102, T-CORE1101 Intergroup study (HERBIS-1 trial)
A phase ll study of Trastuzumab in combination with triweekly S-1 plus CDDP in HER2-positive advanced gastric cancer; OGSG1101, HGCSG1102, T-CORE1101 Intergroup study(HERBIS-1 trial)
Multicenter phase II study of triplet combination chemotherapy with paclitaxel, cisplatin, and S-1 for advanced gastric cancer (OGSG0703)
A Randomized Controlled Phase III Trial to Evaluate the Effect of Preoperative Enteral Immunonutrition on the Surgical Site Infection after Total Gastrectomy (OGSG0507)
A Randomized Controlled Trial of Antimicrobial Prophylaxis Infusion after Gastric Cancer Surgery（OGSG0501）
Randomized phase II trial of S-1 plus irinotecan versus S-1 plus paclitaxelas first-line treatment for advanced gastric cancer (OGSG0402)
A phase II study of systemic chemotherapy with TS-1 combined with cisplatin followed by surgery in advanced gastric cancer (OGSG0004)
A randomized controlled trial to evaluate the effect of preoperative enteral immunonutrition on the surgical site infection after total gastrectomy（OGSG0507）
Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG0604)